Gastrointestinal Drug Market Report 2022: Trends, Forecast and Competitive Analysis, 2016-2027 by Drug Class, Route of Administration, Application, Distribution Channel – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Gastrointestinal Drug Market Report: Trends, Forecast and Competitive Analysis” report has been added to ResearchAndMarkets.com’s offering.

The global gastrointestinal drug market is expected to grow with a CAGR of 4%-6% from 2022 to 2027.

The future of the gastrointestinal drug market looks promising with opportunities in the cure of gastro-esophageal reflux disease, inflammatory bowel disease, and irritable bowel syndrome disorders/applications.

The major drivers for this market are increasing number of gastrointestinal disorder/diseases among the old age people, increasing expenditure in the expansion of healthcare infrastructure coupled with government investment life science and the healthcare sector, and trials conducted by various pharmaceutical companies for introduction of new products.

The study includes a forecast for the global gastrointestinal drug market by drug class, route of administration, application, distribution channel, and region.

Gastrointestinal Drug Market Insight

The analyst forecasts within the global gastrointestinal drug market, the acid neutralizers will remain the largest segment and witness highest growth due to increasing consumption of antacid by growing geriatric population that are suffering from Gastroesophageal Reflux Disease (GERD), higher incidences of acidity due to unhealthy lifestyle, and side-effects of non-steroidal drugs and anti-inflammatory drugs.

North America is expected to remain the largest market due to large number of geriatric population, lifestyles and eating habits (fast food eating), and increasing lifestyle diseases in North America region.

List of Gastrointestinal Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain.

With these strategies gastrointestinal drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base.

Some of the gastrointestinal drug companies profiled in this report include

• Takeda Pharmaceuticals
• Novo Nordisk A/S
• AstraZeneca Plc
• Johnson & Johnson
• AbbVie Inc. (Allergan Plc)
• Bausch Health Companies Inc.(Valeant Pharmaceuticals Inc.)
• Bayer AG
• Boehringer Ingelheim GmbH
• GlaxoSmithKline Plc.

Key Topics Covered:

1. Executive Summary

2. Market Background and Classifications

2.1: Introduction, Background, and Classifications

2.2: Supply Chain

2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2016 to 2027

3.1: Macroeconomic Trends (2016-2021) and Forecast (2022-2027)

3.2: Global Gastrointestinal Drug Market Trends (2016-2021) and Forecast (2022-2027)

3.3: Global Gastrointestinal Drug Market by Drug Class

3.3.1: Acid Neutralizers

3.3.2: Antidiarrheal and Laxatives

3.3.3: Antiemetic and Antinauseants

3.3.4: Anti-inflammatory Drugs

3.3.5: Biologics

3.3.6: Others (Antispasmodic etc.)

3.4: Global Gastrointestinal Drug Market by Route of Administration

3.4.1: Oral

3.4.2: Intravenous

3.4.3: Rectal

3.5: Global Gastrointestinal Drug Market by Application/Disorder Type

3.5.1: Gastro-esophageal Reflux Disease

3.5.2: Inflammatory Bowel Disease

3.5.3: Irritable Bowel Syndrome

3.6: Global Gastrointestinal Drug Market by Distribution Channel

3.6.1: Hospital Pharmacies

3.6.2: Retail Pharmacies

3.6.3: Online Pharmacies

4. Market Trends and Forecast Analysis by Region from 2016 to 2027

4.1: Global Gastrointestinal Drug Market by Region

4.2: North American Gastrointestinal Drug Market

4.2.1: Market by Application: Gastro-Esophageal Reflux Disease, Inflammatory Bowel Disease, Irritable Bowel Syndrome

4.2.2: Market by Drug Class: Acid Neutralizers, Antidiarrheal And Laxatives, Antiemetic And Antinauseants, Anti-Inflammatory Drugs, Biologics, Others

4.2.3: United States Gastrointestinal Drug Market

4.2.4: Canadian Gastrointestinal Drug Market

4.2.5: Mexican Gastrointestinal Drug Market

4.3: European Gastrointestinal Drug Market

4.4: APAC Gastrointestinal Drug Market

4.5: ROW Gastrointestinal Drug Market

5. Competitor Analysis

5.1: Product Portfolio Analysis

5.2: Geographical Reach

5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis

6.1.1: Growth Opportunities for the Global Gastrointestinal Drug Market by Application Type

6.1.2: Growth Opportunities for the Global Gastrointestinal Drug Market by Co-Catalyst Type

6.1.3: Growth Opportunities for the Global Gastrointestinal Drug Market by Region

6.2: Emerging Trends in the Global Gastrointestinal Drug Market

6.3: Strategic Analysis

6.3.1: New Product Development

6.3.2: Capacity Expansion of the Global Gastrointestinal Drug Market

6.3.3: Mergers and Acquisitions, and Joint Ventures in the Global Gastrointestinal Drug Industry

7. Company Profiles of Leading Players

• Takeda Pharmaceuticals
• Novo Nordisk A/S
• AstraZeneca Plc
• Johnson & Johnson
• AbbVie Inc.(Allergan Plc)
• Bausch Health Companies Inc. (Valeant Pharmaceuticals Inc.)
• Bayer AG
• Boehringer Ingelheim GmbH
• GlaxoSmithKline Plc.

For more information about this report visit https://www.researchandmarkets.com/r/rgffy3

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900